Literature DB >> 31283946

Thiosemicarbazone derivatives: Design, synthesis and in vitro antimalarial activity studies.

Ramkishore Matsa1, Parameshwar Makam2, Meenakshi Kaushik3, S L Hoti3, Tharanikkarasu Kannan4.   

Abstract

Different types of thiosemicarbazone derivatives were designed and tested for their Drug-Like Molecular (DLM) nature by using Lipinski and Veber rules. Subsequently, compounds with DLM properties were synthesized and characterized by spectral methods. In vitro antimalarial activity studies of the synthesized thiosemicarbazone derivatives have been carried out against Plasmodium falciparum, 3D7 strain using fluorescence assay method and found that the compounds, (E)-2-(1-(4-fluorophenyl)ethylidene)hydrazine-1-carbothioamide (6), (E)-2-(1-(3-bromophenyl) ethylidene) hydrazine-1-carbothioamide (15) and (E)-2-(3,4,5-trimethoxybenzylidene) hydrazine-1-carbothioamide (29) showed notable antimalarial activity with EC50 values of 13.54 μM, 15.83 μM and 14.52 μM respectively.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  3D7 strain; Antimalarial activity; Fluorescence assay; Plasmodium falciparum; Thiosemicarbazone

Year:  2019        PMID: 31283946     DOI: 10.1016/j.ejps.2019.104986

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  7 in total

1.  Protective Effects of an Oxovanadium(IV) Complex with N2O2 Chelating Thiosemicarbazone on Small Intestine Injury of STZ-Diabetic Rats.

Authors:  Sevim Tunali; Selda Gezginci-Oktayoglu; Sehnaz Bolkent; Ediz Coskun; Tulay Bal-Demirci; Bahri Ulkuseven; Refiye Yanardag
Journal:  Biol Trace Elem Res       Date:  2020-07-09       Impact factor: 3.738

2.  Pyridine appended 2-hydrazinylthiazole derivatives: design, synthesis, in vitro and in silico antimycobacterial studies.

Authors:  Ramkishore Matsa; Parameshwar Makam; Guneswar Sethi; Ahammed Ameen Thottasseri; Aswani Raj Kizhakkandiyil; Krishna Ramadas; Vignesh Mariappan; Agieshkumar Balakrishna Pillai; Tharanikkarasu Kannan
Journal:  RSC Adv       Date:  2022-06-22       Impact factor: 4.036

3.  Design and Synthesis of Novel Betulin Derivatives Containing Thio-/Semicarbazone Moieties as Apoptotic Inducers through Mitochindria-Related Pathways.

Authors:  Jiafeng Wang; Jiale Wu; Yinglong Han; Jie Zhang; Yu Lin; Haijun Wang; Jing Wang; Jicheng Liu; Ming Bu
Journal:  Molecules       Date:  2021-10-21       Impact factor: 4.411

4.  Evaluation of Toxicity and Oxidative Stress of 2-Acetylpyridine-N(4)-orthochlorophenyl Thiosemicarbazone.

Authors:  Andressa Brito Lira; Gabrieli Lessa Parrilha; Gabriela Tafaela Dias; Fernanda Samara de Sousa Saraiva; Gabriel Corrêa Veríssimo; Rayane Siqueira de Sousa; Teresinha Gonçalves da Silva; Abrahão Alves de Oliveira Filho; Adriano Francisco Alves; Elaine Maria de Souza-Fagundes; Heloisa Beraldo; Maria Aparecida Gomes; Margareth de Fatima Formiga Melo Diniz
Journal:  Oxid Med Cell Longev       Date:  2022-03-19       Impact factor: 6.543

Review 5.  Mechanistic Insights of Chelator Complexes with Essential Transition Metals: Antioxidant/Pro-Oxidant Activity and Applications in Medicine.

Authors:  Viktor A Timoshnikov; Olga Yu Selyutina; Nikolay E Polyakov; Victoria Didichenko; George J Kontoghiorghes
Journal:  Int J Mol Sci       Date:  2022-01-23       Impact factor: 5.923

6.  Acetylene containing 2-(2-hydrazinyl)thiazole derivatives: design, synthesis, and in vitro and in silico evaluation of antimycobacterial activity against Mycobacterium tuberculosis.

Authors:  Lakshmi Haritha Bharathi Maganti; Deepthi Ramesh; Balaji Gowrivel Vijayakumar; Mohd Imran K Khan; Arunkumar Dhayalan; Jayabal Kamalraja; Tharanikkarasu Kannan
Journal:  RSC Adv       Date:  2022-03-21       Impact factor: 3.361

7.  Bis-pharmacophore of cinnamaldehyde-clubbed thiosemicarbazones as potent carbonic anhydrase-II inhibitors.

Authors:  Asif Rasool; Zahra Batool; Majid Khan; Sobia Ahsan Halim; Zahid Shafiq; Ahmed Temirak; Mohamed A Salem; Tarik E Ali; Ajmal Khan; Ahmed Al-Harrasi
Journal:  Sci Rep       Date:  2022-09-27       Impact factor: 4.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.